Krishna Institute of Medical Sciences Results Update

Other Announcement

Krishna Institute of Medical Sciences Other Announcement

KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.

Management Change

Krishna Institute of Medical Sciences Management Change

KIMS re-appointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as CMD, and Ms. Dandamudi Anitha as Whole-time Director. Terms start in 2027.

Execution

5 years

Earnings Call

Krishna Institute of Medical Sciences Investor Presentation: Key Takeaways

Q2 FY27 total revenue Rs13,630 Mn (+41.3% YoY), EBITDA Rs2,789 Mn (20.5% margin), PAT Rs757 Mn (+5.1% YoY). Expansion via 700+ beds planned.

Financial Results

Krishna Institute of Medical Sciences Q2 FY27 Results: Net Profit ₹74.6 Cr, Up 3.6% YoY

Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,344 Cr (+39.9% YoY) and net profit of ₹74.6 Cr (+3.6% YoY) for Q2 FY27.

Key figure

Net profit ₹74.6 Cr · +3.6% YoY

Capacity Expansion

Krishna Institute of Medical Sciences Capacity Expansion

KIMS Saveera Hospital in Anantapur expanded from 250 to 500 beds, with new oncology and mother-and-child blocks inaugurated November 1, 2026. No monetary value disclosed.

hospital beds

250.0 beds

Acquisition

Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr

KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.

Value

₹15.00 Cr

Results UpdateGoel Construction Company Ltd 544504

Goel Construction Company Results Update

Goel Construction reported strong H1 FY27 unaudited results with rising revenue and profit. Its order book nearly doubled to about Rs.2,375 crore.

Results UpdateTPL Plastech Ltd TPLPLASTEH

TPL Plastech Results Update

TPL Plastech's Q2 FY27 revenue rose 39.9% to ₹1,495.2 Mn, and PAT rose 22.3% to ₹83.8 Mn. It also notes a Bhuj plant start and a parent merger.

Results UpdateVindhya Telelinks Ltd VINDHYATEL

Vindhya Telelinks Results Update

Vindhya Telelinks reported Q2 FY27 standalone PAT of ₹5781.42 lakhs, up 82% year-on-year, with Cable EBITDA up over 250%. The press release also covers EPC receivables and the proposed Birla Cable amalgamation.

Results UpdateGolkunda Diamonds & Jewellery Ltd GOLKUNDIA

Golkunda Diamonds & Jewellery Results Update

Golkunda Diamonds reported Q2 FY27 PAT up 113.23% and revenue up 7.92%. It also launched NIBHANA, a lab-grown diamond jewellery retail brand, with four stores open.

NIBHANA retail stores

4.0 stores

Results UpdateGodavari Biorefineries Ltd GODAVARIB

Godavari Biorefineries Results Update

Q2 FY27 revenue rose 26.6% YoY to Rs.549.8 Crore, with EBITDA turning positive. Net loss narrowed to Rs.15.2 Crore from Rs.41.6 Crore a year earlier.

Results UpdateAurobindo Pharma Ltd AUROPHARMA

Aurobindo Pharma Results Update

Aurobindo Pharma reported Q2 FY27 revenue of Rs.10,263 Crore, up 23.9% YoY, and net profit of Rs.1,124 Crore. An interim dividend of Rs.7 per share was declared.